TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study

被引:19
作者
Coon, H
Singh, N
Dunn, D
Eckfeldt, JH
Province, MA
Hopkins, PN
Weiss, R
Hunt, SC
Leppert, MF
机构
[1] Univ Utah, Neurodev Genet Project, Salt Lake City, UT 84108 USA
[2] Univ Utah, Dept Human Genet, Salt Lake City, UT 84108 USA
[3] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[4] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[5] Univ Utah, Dept Internal Med, Salt Lake City, UT 84108 USA
关键词
hyperlipiderma; FCHL; TXNIP; association; linkage;
D O I
10.1016/j.atherosclerosis.2004.02.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Familial combined hyperlipidemia (FCHL) is the most common familial dyslipidemia, and is implicated in up to 20% of cases of premature coronary heart disease. Positive linkage to chromosome 1q was found in FCHL families participating in the NHLBI Family Heart Study (FHS), replicating linkage found in other studies. The HcB-19 mouse, which shares phenotypes with FCHL, was shown in other studies to have a nonsense mutation in the thioredoxin interacting protein gene (txnip). txnip is a gene on mouse chromosome 3 in a region syntenic with the 1q human FCHL linkage region. We re-sequenced the human homolog of mouse txnip in the FHS sample and identified nine single nucleotide polymorphisms (SNPs). We did not observe the nonsense mutation found in the HcB-19 mouse, and only three of the SNPs discovered were sufficiently polymorphic for analysis. No association between FCHL and the TXNIP gene was found. Within FCHL cases, presence of variants also did not significantly affect body mass index or levels of lipids, insulin, or glucose. Our results suggest that in this sample, TXNIP does not play a major role in FCHL or related traits, and is unlikely to account for the positive evidence of linkage in this region. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:357 / 362
页数:6
相关论文
共 22 条
[1]   Positional cloning of the combined hyperlipidemia gene Hyplip1 [J].
Bodnar, JS ;
Chatterjee, A ;
Castellani, LW ;
Ross, DA ;
Ohmen, J ;
Cavalcoli, J ;
Wu, CY ;
Dains, KM ;
Catanese, J ;
Chu, M ;
Sheth, SS ;
Charugundla, K ;
Demant, P ;
West, DB ;
de Jong, P ;
Lusis, AJ .
NATURE GENETICS, 2002, 30 (01) :110-116
[2]   Mapping a gene for combined hyperlipidaemia in a mutant mouse strain [J].
Castellani, LW ;
Weinreb, A ;
Bodnar, J ;
Goto, AM ;
Doolittle, M ;
Mehrabian, M ;
Demant, P ;
Lusis, AJ .
NATURE GENETICS, 1998, 18 (04) :374-377
[3]   Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III-IV locus - The NHLBI Family Heart Study [J].
Coon, H ;
Myers, RH ;
Borecki, IB ;
Arnett, DK ;
Hunt, SC ;
Province, MA ;
Djousse, L ;
Leppert, MF .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (10) :2275-2280
[4]   Base-calling of automated sequencer traces using phred.: I.: Accuracy assessment [J].
Ewing, B ;
Hillier, L ;
Wendl, MC ;
Green, P .
GENOME RESEARCH, 1998, 8 (03) :175-185
[5]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[6]   FAMILIAL LIPOPROTEIN DISORDERS IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
MARTINMUNLEY, SS ;
MCNAMARA, JR ;
ORDOVAS, JM ;
JENNER, J ;
MYERS, RH ;
SILBERMAN, SR ;
WILSON, PWF ;
SALEM, DN ;
SCHAEFER, EJ .
CIRCULATION, 1992, 85 (06) :2025-2033
[7]   HYPERLIPIDEMIA IN CORONARY HEART-DISEASE .2. GENETIC ANALYSIS OF LIPID-LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA [J].
GOLDSTEIN, JL ;
SCHROTT, HG ;
HAZZARD, WR ;
BIRMAN, EL ;
MOTULSKY, AG .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (07) :1544-1568
[8]  
GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203
[9]  
Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709
[10]  
Kruglyak L, 1996, AM J HUM GENET, V58, P1347